Related Experiment Video
Updated: Sep 12, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Monotherapy Immunosuppression in Pediatric Heart Transplant Recipients
Elizabeth L Profita1, Joanne Lee2, Donna Lee2
1Department of Pediatrics (Cardiology), Stanford University, Palo Alto, California, USA.
Pediatric heart transplant patients on single-drug immunosuppression (monotherapy) showed no increased rejection risk. This approach may be suitable for select patients experiencing over-immunosuppression, improving outcomes.
Area of Science:
- Pediatric Cardiology
- Transplantation Immunology
- Immunosuppression Therapy
Background:
- Standard immunosuppression after pediatric heart transplant (HT) involves dual drugs.
- Single-drug immunosuppression (monotherapy) may be an option for select patients.
- This study evaluates monotherapy in a pediatric HT cohort.
Purpose of the Study:
- To assess the efficacy and safety of calcineurin inhibitor monotherapy in pediatric heart transplant recipients.
- To determine if monotherapy is associated with increased risk of rejection or adverse events.
- To identify patient subgroups who may benefit from reduced immunosuppression.
Main Methods:
- Retrospective review of pediatric heart transplant patients (2001-2020).
- Analysis of patients on calcineurin inhibitor monotherapy for over one month.
- Evaluation of clinical characteristics, reasons for transition to monotherapy, and patient outcomes.
Main Results:
- 5% (16/318) of patients transitioned to monotherapy, primarily due to recurrent infection, PTLD, or neutropenia.
- No moderate or greater rejection episodes or coronary allograft vasculopathy were observed.
- 94% of patients remained alive and well at last follow-up, with 87% continuing monotherapy.
Conclusions:
- Calcineurin inhibitor monotherapy can be a safe and effective strategy for select pediatric heart transplant patients.
- Monotherapy may be preferred in patients with signs of over-immunosuppression.
- This approach does not appear to increase the risk of rejection.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Myocarditis III: Medical Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

